Phynova, the innovative life science company that develops and markets proprietary medicinal products derived from active compounds found in plants, has been awarded the “Global Leader in Plant-Based Compounds and Pharmaceuticals and Best Natural Pain Reliever” award by Global Health & Pharma magazine (GHP). GHP is a global information sharing platform & a multi-disciplinary members community. Established to enhance communication networks & collaboration across all themes and disciplines within 3 main categories; Human, Animal & Environmental Health. Whilst the membership is organically grown and closely audited, members have tended to fall into a number of general categories; Academia, Industry, Public Bodies & Health Systems, Governments & Policy Makers, Funding Agencies & Groups, Investors, Regulatory & Professional Bodies.
Founded in 2002, the Oxford-based life sciences firm has specialised in developing high quality plant-derived products for use in both consumer healthcare and food industries. With its multidisciplinary team of experts, Phynova has assembled specialists in traditional Chinese medicine, phytochemistry, pharmacology, and clinical development. Phynova differentiates itself through its methodological, scientific approach, employing the highest levels of quality and applying scientific rigour to validate its products. Phynova’s expertise and innovation in plant-based medicines has been recognised with this award.
Phynova has developed a range of commercial products that are in or ready to enter the UK healthcare market. This includes Phynova Joint and Muscle Relief Tablets™, which contributed to it winning the accolade of “Global Leader in Plant-Based Compounds and Pharmaceuticals and Best Natural Pain Reliever”. The product contains an extract of Sigesbeckia orientalis as the active ingredient, a plant that has been historically used in oriental medicine to treat all forms of arthritis, joint and back pain. Phynova’s expertise in plant-based medicine allowed it to become the first company to achieve UK regulatory approval for a traditional Chinese medicine, culminating in Phynova Joint and Muscle Relief Tablets™ being licensed as an over the counter medicine by the Medicines and Healthcare Products Regulatory Agency (“MHRA”) in March, 2015.